Switching from sulfonylurea to sitagliptin among type 2 diabetic patients in combination with metformin or pioglitazone.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Sitagliptin (Primary) ; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Jul 2012 New trial record